Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)

NCT06902844 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus (SLE)
Lupus Nephritis (LN)

Interventions

DRUG: Equecabtagene Autoleucel Injection

Sponsor

Tongji Hospital

Collaborators

[object Object]